Technical Insights Session 3: Salt AI Platform Demo: Contextual AI-enabled protein design for oncology targets | Kisaco Research
  • The future requires systems that connect data, models, and tools
  • Salt AI platform enables companies to deploy, build, optimize, and run multi-model systems
  • Proven impact in drug discovery with complex protein design pipeline
Sponsor(s): 
Salt AI
Speaker(s): 

Author:

Dan Sheikh

VP, AI Solutions
Salt AI

Dan Sheikh is a technology strategist and AI innovator specializing in applying artificial intelligence and data science in regulated industries. With advanced degrees from University College London and the UCLA Anderson School of Management, he bridges deep technical expertise with strategic insight to design AI solutions that are powerful, compliant, and scalable. His work focuses on driving responsible digital transformation that aligns innovation with operational value and regulatory integrity.

Dan Sheikh

VP, AI Solutions
Salt AI

Dan Sheikh is a technology strategist and AI innovator specializing in applying artificial intelligence and data science in regulated industries. With advanced degrees from University College London and the UCLA Anderson School of Management, he bridges deep technical expertise with strategic insight to design AI solutions that are powerful, compliant, and scalable. His work focuses on driving responsible digital transformation that aligns innovation with operational value and regulatory integrity.

Author:

Toby Sayre

VP, Business Development
Salt AI

Toby Sayre is a commercial leader with a background in life sciences and biotechnology consulting, business development, and product strategy. He holds master’s degrees in Cell and Molecular Biology and Biochemistry from San Francisco State University and UCLA. His work bridges bioinformatics, real-world data, and AI-driven software, integrating technical and commercial expertise to advance innovation in the life sciences.

Toby Sayre

VP, Business Development
Salt AI

Toby Sayre is a commercial leader with a background in life sciences and biotechnology consulting, business development, and product strategy. He holds master’s degrees in Cell and Molecular Biology and Biochemistry from San Francisco State University and UCLA. His work bridges bioinformatics, real-world data, and AI-driven software, integrating technical and commercial expertise to advance innovation in the life sciences.

Time: 
11:20AM - 11:30AM
Session Type: 
General Session (Presentation)